Health Care Down as Retreat From Sector Continues -- Health Care Roundup

Dow Jones05-16 05:41

Health-care companies fell as a retreat from the sector continued.

The Supreme Court maintained widespread access to a common abortion pill, allowing doctors to continue mailing the drug to patients without first seeing them in person.

Contract drug manufacturers look set to benefit from the U.S. government's accelerated push to bring more pharmaceutical production onshore, said analysts at brokerage RBC Capital Markets, in a research note.

Amgen shares ticked down after reports that 20 people in Japan who took the biotech firm's rare-disease drug Tavneos have died, and at least 22 developed a potentially fatal liver injury. The disclosures were made by Kissei Pharmaceutical, which sells the medicine in the country.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

May 15, 2026 17:41 ET (21:41 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635005393?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-16 05:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635005393","market":"sh","top_or_hot":-1,"title":"Health Care Down as Retreat From Sector Continues -- Health Care Roundup","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health-care companies fell as a retreat from the sector continued. \n</p>\n<p>\n  The Supreme Court maintained widespread access to a common abortion pill, allowing doctors to continue mailing the drug to patients without first seeing them in person. \n</p>\n<p>\n  Contract drug manufacturers look set to benefit from the U.S. government's accelerated push to bring more pharmaceutical production onshore, said analysts at brokerage RBC Capital Markets, in a research note. \n</p>\n<p>\n  Amgen shares ticked down after reports that 20 people in Japan who took the biotech firm's rare-disease drug Tavneos have died, and at least 22 developed a potentially fatal liver injury. The disclosures were made by Kissei Pharmaceutical, which sells the medicine in the country. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 15, 2026 17:41 ET (21:41 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Health Care Down as Retreat From Sector Continues -- Health Care Roundup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealth Care Down as Retreat From Sector Continues -- Health Care Roundup\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-05-16 05:41</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health-care companies fell as a retreat from the sector continued. \n</p>\n<p>\n  The Supreme Court maintained widespread access to a common abortion pill, allowing doctors to continue mailing the drug to patients without first seeing them in person. \n</p>\n<p>\n  Contract drug manufacturers look set to benefit from the U.S. government's accelerated push to bring more pharmaceutical production onshore, said analysts at brokerage RBC Capital Markets, in a research note. \n</p>\n<p>\n  Amgen shares ticked down after reports that 20 people in Japan who took the biotech firm's rare-disease drug Tavneos have died, and at least 22 developed a potentially fatal liver injury. The disclosures were made by Kissei Pharmaceutical, which sells the medicine in the country. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 15, 2026 17:41 ET (21:41 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2635005393","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2635005393","pubTimestamp":1778881260,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Health-care companies fell as a retreat from the sector continued.The Supreme Court maintained widespread access to a common abortion pill, allowing doctors to continue mailing the drug to patients without first seeing them in person.Contract drug manufacturers look set to benefit from the U.S. government's accelerated push to bring more pharmaceutical production onshore, said analysts at brokerage RBC Capital Markets, in a research note.Amgen shares ticked down after reports that 20 people in Japan who took the biotech firm's rare-disease drug Tavneos have died, and at least 22 developed a potentially fatal liver injury. The disclosures were made by Kissei Pharmaceutical, which sells the medicine in the country.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","XBI":"SPDR S&P Biotech ETF","LABU":"三倍做多标普生物-Direxion","BK4588":"碎股","BK4585":"ETF&股票定投概念","XLV":"健康照护类股ETF-SPDR"},"translate_title":"医疗保健行业继续撤退，医疗保健下降——医疗保健综述","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":0.6,"XBI":0.6,"XLV":1.5},"content_text":"Health-care companies fell as a retreat from the sector continued. \n\n\n  The Supreme Court maintained widespread access to a common abortion pill, allowing doctors to continue mailing the drug to patients without first seeing them in person. \n\n\n  Contract drug manufacturers look set to benefit from the U.S. government's accelerated push to bring more pharmaceutical production onshore, said analysts at brokerage RBC Capital Markets, in a research note. \n\n\n  Amgen shares ticked down after reports that 20 people in Japan who took the biotech firm's rare-disease drug Tavneos have died, and at least 22 developed a potentially fatal liver injury. The disclosures were made by Kissei Pharmaceutical, which sells the medicine in the country. \n\n\n \n\n\n  Write to Rob Curran at rob.curran@dowjones.com \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2026 17:41 ET (21:41 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635005393","isCrawlerRequest":true}